Medical Condition News

RSS

Ampyra receives FDA approval for improving walking in MS patients

The U.S. Food and Drug Administration today approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use.

23 Jan 2010

Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial

Biovail Corporation today commented on a proposed clinical trial recently announced by Teva Pharmaceutical Industries Ltd. According to Teva, the trial is intended to address reports of inefficacy and adverse events by consumers who switched from Wellbutrin XL® 300 mg, Biovail’s FDA-approved brand of the antidepressant, bupropion hydrochloride, to Budeprion XL, Teva’s generic formulation of the drug. The trial was described in a Dow Jones Newswire article dated December 2, 2009.

22 Jan 2010

Study shows certain heart medications may decrease risk of Parkinson's disease

UCLA researchers have discovered that a specific type of medication used to treat cardiovascular conditions such as hypertension, angina and abnormal heart rhythms may also decrease the risk of developing Parkinson's disease.

22 Jan 2010

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

GenVec, Inc. announced today that data from the Company's trial in esophageal cancer were presented at the American Society of Clinical Oncology's 2010 Gastrointestinal Cancer Symposium in Orlando, Florida on January 22, 2010.

22 Jan 2010

NIH awards grants to develop new tobacco-related drug therapies

Four scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center have been awarded more than $2.2 million from the National Institutes of Health (NIH) to research the effects of nicotine and develop new tobacco-related drug therapies.

22 Jan 2010

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Acorda Therapeutics, Inc. today announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for AMPYRA™ (dalfampridine), an oral treatment to improve walking in patients with multiple sclerosis (MS).

22 Jan 2010

Researchers produce DVD to help patients live with and manage neuropathic pain

Health professionals and patients can now go online for help and tips from a groundbreaking pain clinic, which halved referrals to hospital.

22 Jan 2010

Findings offer potential significance to the recovery of walking after spinal cord injury

Researchers at the medical university Karolinska Institutet have created a genetically modified mouse in which certain neurons can be activated by blue light. Shining blue light on brainstems or spinal cords isolated from these mice produces walking-like motor activity. The findings, which are published in the scientific journal Nature Neuroscience, are of potential significance to the recovery of walking after spinal cord injury.

22 Jan 2010

ACS Chemical Biology report supports zebrafish for drug development

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

22 Jan 2010

NCD calls for policymakers to proactively address shortages in disability workforce infrastructure

The National Council on Disability (NCD) today released a report titled Workforce Infrastructure in Support of People with Disabilities: Matching Human Resources to Service Needs, calling for policymakers at all levels of government to proactively address current shortages and examine how labor market changes are driving both current and future supply.

22 Jan 2010

Seven-time PGA TOUR winner designates funds to the National Fragile X Foundation

Seven-time PGA TOUR winner Steve Stricker has recently designated a check in the amount of $10,000 to the National Fragile X Foundation. This contribution is a portion of the charitable proceeds generated from The Presidents Cup 2009 at Harding Park Golf Course in San Francisco, California, in which Stricker participated as a member of the victorious U.S. Team for the third time in his career.

22 Jan 2010

Combat injuries are not the leading cause of medical evacuation from war zones

The most common reasons for medical evacuation of military personnel from war zones in Iraq and Afghanistan in recent years have been fractures, tendonitis and other musculoskeletal and connective tissue disorders, not combat injuries, according to results of a Johns Hopkins study published January 22 in The Lancet.

22 Jan 2010

The American Journal of Pathology: Highlights from February 2010 issue

A group led by Dr. Peter Lloyd Jones at the University of Dundee, Dundee, Scotland; the University of Colorado Denver, Aurora, CO; and the University of Pennsylvania, Philadelphia, PA has demonstrated that tenascin-C affects proto-oncogene function in breast cancer. Their report can be found in the February 2010 issue of The American Journal of Pathology.

22 Jan 2010

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting exceptional early career researchers and innovative cancer research, named 11 new Damon Runyon Fellows at its November 2009 Fellowship Award Committee review.

22 Jan 2010

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper “An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure” was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).

22 Jan 2010

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Researchers at the University of Southern California (USC) have, for the first time, identified specific genetic variations that predict clinical outcomes in patients with gastric (stomach) cancer.

22 Jan 2010

Fluctuation in insulin delivery due to pump movement may increase risk of complications in diabetics

Researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact expected insulin delivery rates. Such changes can occur during routine daily activities like dressing, sleeping or showering.

22 Jan 2010

Physicians take measures to treat ADHD on college campuses across the country

In college, students with attention deficit/hyperactive disorder face an array of challenges—long days and nights of classes, studying and activities, all of which require increasing amounts of concentration.

22 Jan 2010

Researchers to study the impact of asthma on sleep and academic performance of young children

Bradley Hasbro Children's Research Center and Hasbro Children's Hospital researchers have received more than $2.5 million in direct costs from The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to study the impact of asthma on the sleep quality and academic performance of young children.

22 Jan 2010

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

Low vitamin D blood levels are associated with a significantly higher risk of relapse attacks in patients with multiple sclerosis (MS) who develop the disease during childhood, according to a study conducted by researchers from the University of California, San Francisco.

22 Jan 2010

Medical Condition News

Ampyra receives FDA approval for improving walking in MS patients

Biovail comments on Teva Pharmaceutical's proposed Budeprion XL trial

Study shows certain heart medications may decrease risk of Parkinson's disease

Data from GenVec's trial in esophageal cancer showcased at 2010 Gastrointestinal Cancer Symposium

NIH awards grants to develop new tobacco-related drug therapies

Acorda Therapeutics receives marketing approval from FDA for AMPYRA

Researchers produce DVD to help patients live with and manage neuropathic pain

Findings offer potential significance to the recovery of walking after spinal cord injury

ACS Chemical Biology report supports zebrafish for drug development

NCD calls for policymakers to proactively address shortages in disability workforce infrastructure

Seven-time PGA TOUR winner designates funds to the National Fragile X Foundation

Combat injuries are not the leading cause of medical evacuation from war zones

The American Journal of Pathology: Highlights from February 2010 issue

Postdoctoral scientists receive prestigious award; grants totaling $1.54 million will help in funding innovative projects

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

Researchers discover genetic variations that predict clinical outcomes in patients with stomach cancer

Fluctuation in insulin delivery due to pump movement may increase risk of complications in diabetics

Physicians take measures to treat ADHD on college campuses across the country

Researchers to study the impact of asthma on sleep and academic performance of young children

Vitamin D insufficiency associated with higher risk of relapse attacks in patients with MS

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News